Haemophilia
-
Publication Venue For
- Women and girls with haemophilia: Lessons learned.. 27 Suppl 3:75-81. 2021
- Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding.. 24:63-69. 2018
- A prospective study of von Willebrand factor levels and bleeding in pregnant women with type 1 von Willebrand disease.. 22:e562-e564. 2016
- State of the art: von Willebrand disease.. 22 Suppl 5:54-59. 2016
- Von Willebrand factor for menorrhagia: a survey and literature review.. 22:397-402. 2016
- Coated platelet assay: a feasible approach to a complicated science.. 22:e67-e70. 2016
- Coated platelets and severe haemophilia A bleeding phenotype: Is there a connection?. 22:148-151. 2016
- Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis.. 21:81-87. 2015
- Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials.. 21:34-40. 2015
- Assessing patients' and caregivers' perspectives on stability of factor VIII products for haemophilia A: a web-based study in the United States and Canada.. 20:e296-e303. 2014
- Progressive improvement in wound healing with increased therapy in haemophilia B mice.. 19:926-932. 2013
- Successful prophylactic regimens for transvaginal oocyte retrieval in women with bleeding diatheses.. 19:e189-e191. 2013
- Acquired, non-amyloid related factor X deficiency: review of the literature.. 18:655-663. 2012
- Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyond.. 18 Suppl 4:112-119. 2012
- The clotting system - a major player in wound healing.. 18 Suppl 5:11-16. 2012
- Factor X deficiency and pregnancy: preconception counselling and therapeutic options.. 18:e277-e285. 2012
- Diagnosis and management of women with bleeding disorders--international guidelines and consensus from an international expert panel.. 17 Suppl 1:3-5. 2011
- Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres.. 17 Suppl 1:6-13. 2011
- Women and bleeding disorders.. 16 Suppl 5:160-167. 2010
- The optimal mode of delivery for the haemophilia carrier expecting an affected infant is caesarean delivery.. 16:420-424. 2010
- Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.. 16:510-517. 2010
- Wound healing in haemophilia--breaking the vicious cycle.. 16 Suppl 3:13-18. 2010
- Risk factors for inhibitor formation in haemophilia: a prevalent case-control study.. 15:1074-1082. 2009
- von Willebrand disease in the 21st century: current approaches and new challenges.. 15:1154-1158. 2009
- Complications of hysterectomy in women with von Willebrand disease.. 15:926-931. 2009
- Celecoxib does not delay cutaneous wound healing in haemophilia B mice.. 15:615-616. 2009
- Animal models of bleeding and tissue repair.. 14 Suppl 3:62-67. 2008
- von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).. 14:171-232. 2008